Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study.

Rinaldetti S, Chepeleva M, Hedblom A, Sticht C, Muciek M, Panayiotidis P, Richter J, Olsson-Strömberg U, Nowak D, Nowak V, Ljungman P, von Bubnoff N, Lotfi K, Stenke L, Brümmendorf TH, Hjorth-Hansen H, Gedde-Dahl T, Majeed W, Burchert A, Nazarov PV, Felde E, Tarnopolscaia I, Hoelting C, Fabarius A, Hofmann WK, Mahon FX, Saussele S, Pfirrmann M

Open source

DOI
10.1038/s41375-026-03001-5
Published
2026 Aug
Container
Leukemia
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41375-026-03001-5,
  title = {Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study.},
  author = {Rinaldetti S and Chepeleva M and Hedblom A and Sticht C and Muciek M and Panayiotidis P and Richter J and Olsson-Strömberg U and Nowak D and Nowak V and Ljungman P and von Bubnoff N and Lotfi K and Stenke L and Brümmendorf TH and Hjorth-Hansen H and Gedde-Dahl T and Majeed W and Burchert A and Nazarov PV and Felde E and Tarnopolscaia I and Hoelting C and Fabarius A and Hofmann WK and Mahon FX and Saussele S and Pfirrmann M},
  year = {2026},
  journal = {Leukemia},
  doi = {10.1038/s41375-026-03001-5},
  url = {https://doi.org/10.1038/s41375-026-03001-5}
}

RIS

TY  - JOUR
TI  - Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study.
AU  - Rinaldetti S
AU  - Chepeleva M
AU  - Hedblom A
AU  - Sticht C
AU  - Muciek M
AU  - Panayiotidis P
AU  - Richter J
AU  - Olsson-Strömberg U
AU  - Nowak D
AU  - Nowak V
AU  - Ljungman P
AU  - von Bubnoff N
AU  - Lotfi K
AU  - Stenke L
AU  - Brümmendorf TH
AU  - Hjorth-Hansen H
AU  - Gedde-Dahl T
AU  - Majeed W
AU  - Burchert A
AU  - Nazarov PV
AU  - Felde E
AU  - Tarnopolscaia I
AU  - Hoelting C
AU  - Fabarius A
AU  - Hofmann WK
AU  - Mahon FX
AU  - Saussele S
AU  - Pfirrmann M
PY  - 2026
JO  - Leukemia
DO  - 10.1038/s41375-026-03001-5
UR  - https://doi.org/10.1038/s41375-026-03001-5
ER  - 

APA

S, R., M, C., A, H., C, S., M, M., P, P., J, R., U, O., D, N., V, N., P, L., N, V. B., K, L., L, S., TH, B., H, H., T, G., W, M., A, B., PV, N., E, F., I, T., C, H., A, F., WK, H., FX, M., S, S., & M, P. (2026). Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study.. Leukemia. https://doi.org/10.1038/s41375-026-03001-5

Source records